4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-018047
Chief Commercial Officer sold 3,108 shares at $90.00 ($279,720)
- Chief Commercial Officer acquired 3,108 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Khayal Tamer I · Chief Commercial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,144 | $16.00 | $18,304 | 15,519 | D |
| 2024-02-16 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,714 | $16.14 | $27,664 | 17,233 | D |
| 2024-02-16 | Sale : show line 3 in the form 10b5-1 | −2,858 | $90.00 | $257,220 | 14,375 | D |
| 2024-02-20 | Exercise or conversion : show line 4 in the form 10b5-1 | +250 | $16.14 | $4,035 | 14,625 | D |
| 2024-02-20 | Sale : show line 5 in the form 10b5-1 | −250 | $90.00 | $22,500 | 14,375 | D |
| Open-market sales · 3,108 sh · avg $90.00 · $279,720 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-16 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −1,144 | 0 | D |
| 2024-02-16 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −1,714 | 15,996 | D |
| 2024-02-20 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −250 | 15,746 | D |
Loading xslF345X05/ownership.xml…